Recent radiochemical developments suggest that triazinediamine or butyl-phenyl sulfonamide analogs labeled with [18F] are promising candidate radiotracers for noninvasive PET imaging of IDH mutations in gliomas [179,180]. Here, IDH2 is linked to glioma.